This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nowak, B. Articles by Stellbrink, C. Search for Related Content PubMed PubMed Citation Articles by Nowak, B. Articles by Stellbrink, C.

CLINICAL RESEARCH

Cardiac resynchronization therapyhomogenizes myocardial glucosemetabolism and perfusion in dilatedcardiomyopathy and left bundle branch block

Bernd Nowak, MD^*,*, Anil M. Sinha, MD, PhD, Wolfgang M. Schaefer, MD, PhD^*, Karl-Christian Koch, MD, Hans-Juergen Kaiser, PhD^*, Peter Hanrath, MD, FACC, Udalrich Buell, MD^* and Christoph Stellbrink, MD

^* Department ofNuclear Medicine, University Hospital, Aachen University of Technology, Aachen, Germany
Internal Medicine I (Cardiology), University Hospital, Aachen University of Technology, Aachen, Germany

Manuscript received September 17, 2002; revised manuscript received December 23, 2002, accepted December 27, 2002.

^* Reprint requests and correspondence: Dr. Bernd Nowak, Department of Nuclear Medicine, University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
bnowak{at}ukaachen.de

OBJECTIVES: We investigated whether cardiac resynchronization therapy (CRT) affects myocardial glucose metabolism and perfusion in dilated cardiomyopathy (DCM) and left bundle branch block (LBBB).

BACKGROUND: Patients with DCM and LBBB present with asynchronous left ventricular (LV) activation, leading to reduced septal glucose metabolism. Cardiac resynchronization therapy recoordinates LV activation, but its effects on myocardial glucose metabolism and perfusion remain unknown.

METHODS: In 15 patients (10 females; 61 ± 13 years) with DCM and LBBB (QRS width 165 ± 15 ms), gated ¹⁸F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and technetium-99m (^99mTc)-sestamibi single-photon emission computed tomography were performed before and after two weeks of CRT. Uptake of FDG and ^99mTc-sestamibi was determined in four LV wall areas. Ejection fraction and volumes were calculated from gated PET.

RESULTS: Baseline FDG uptake was heterogeneous (p < 0.0001), with lowest uptake in the septal region (56 ± 12%) and highest uptake in the lateral region (89 ± 6%). During CRT, septal and anterior increases (p < 0.01) and lateral decreases (p < 0.01) resulted in homogeneously distributed glucose metabolism. Baseline heterogeneity (p < 0.0001) in ^99mTc-sestamibi uptake was modest (lowest septal 65 ± 10%; maximum lateral 84 ± 5%) and also reduced with CRT, although some heterogeneity (p < 0.05) remained. The septal-to-lateral ratio increased with CRT for FDG (0.62 ± 0.12 to 0.91 ± 0.26, p < 0.001) and ^99mTc-sestamibi uptake (0.77 ± 0.13 to 0.85 ± 0.16, p < 0.01). The LV end-diastolic and end-systolic volumes decreased from 293 ± 160 to 272 ± 158 ml (p < 0.05) and from 244 ± 164 to 220 ± 160 ml (p < 0.01), respectively. Ejection fraction increased from 22 ± 12% to 25 ± 13% (p < 0.01).

CONCLUSIONS: Glucose metabolism is reduced more than perfusion in the septal compared with LV lateral wall in patients with DCM and LBBB. Cardiac resynchronization therapy restores homogeneous myocardial glucose metabolism with less influence on perfusion.

Abbreviations and Acronyms   CRT = cardiac resynchronization therapy   DCM = dilated cardiomyopathy   FDG = 18F-fluorodeoxyglucose   HF = heart failure   LBBB = left bundle branch block   LV = left ventricular   LVEDV andLVESV = left ventricular end-diastolic and end-systolic volume, respectively   LVEF = left ventricular ejection fraction   PET = positron emission tomography   SPECT = single-photon emission computed tomography   99mTc = technetium-99m

This article has been cited by other articles:

				J. W. Askew, T. Miller, R. Gibbons, and P. Chareonthaitawee Effects of left bundle branch block and right ventricular pacing on assessing myocardial viability by positron emission tomography. J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 661 - 663. [Full Text] [PDF]

				C. Parsai, A. Baltabaeva, L. Anderson, M. Chaparro, B. Bijnens, and G. R. Sutherland Low-dose dobutamine stress echo to quantify the degree of remodelling after cardiac resynchronization therapy Eur. Heart J., April 2, 2009; 30(8): 950 - 958. [Abstract] [Full Text] [PDF]

				M. O. Sweeney and F. W. Prinzen Ventricular Pump Function and Pacing: Physiological and Clinical Integration Circ Arrhythmia Electrophysiol, June 1, 2008; 1(2): 127 - 139. [Full Text] [PDF]

				C. Valzania, F. Gadler, R. Winter, F. Braunschweig, L.-A. Brodin, P. Gudmundsson, G. Boriani, and M. J. Eriksson Effects of cardiac resynchronization therapy on coronary blood flow: Evaluation by transthoracic Doppler echocardiography Eur J Heart Fail, May 1, 2008; 10(5): 514 - 520. [Abstract] [Full Text] [PDF]

				K. Chakir, S. K. Daya, R. S. Tunin, R. H. Helm, M. J. Byrne, V. L. Dimaano, A. C. Lardo, T. P. Abraham, G. F. Tomaselli, and D. A. Kass Reversal of Global Apoptosis and Regional Stress Kinase Activation by Cardiac Resynchronization Circulation, March 18, 2008; 117(11): 1369 - 1377. [Abstract] [Full Text] [PDF]

				M. M. Henneman, E. E. van der Wall, C. Ypenburg, G. B. Bleeker, N. R. van de Veire, N. A. Marsan, J. Chen, E. V. Garcia, J. J.M. Westenberg, M. J. Schalij, et al. Nuclear Imaging in Cardiac Resynchronization Therapy J. Nucl. Med., December 1, 2007; 48(12): 2001 - 2010. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Europace, October 1, 2007; 9(10): 959 - 998. [Full Text] [PDF]

				Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295. [Full Text] [PDF]

				K. Vernooy, R. N.M. Cornelussen, X. A.A.M. Verbeek, W. Y.R. Vanagt, A. van Hunnik, M. Kuiper, T. Arts, H. J.G.M. Crijns, and F. W. Prinzen Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block hearts Eur. Heart J., September 1, 2007; 28(17): 2148 - 2155. [Abstract] [Full Text] [PDF]

				H. Ashrafian, M. P. Frenneaux, and L. H. Opie Metabolic Mechanisms in Heart Failure Circulation, July 24, 2007; 116(4): 434 - 448. [Abstract] [Full Text] [PDF]

				K. Thompson, G. Saab, D. Birnie, B. J.W. Chow, H. Ukkonen, K. Ananthasubramaniam, R. A. deKemp, L. Garrard, T. D. Ruddy, J. N. DaSilva, et al. Is Septal Glucose Metabolism Altered in Patients with Left Bundle Branch Block and Ischemic Cardiomyopathy? J. Nucl. Med., November 1, 2006; 47(11): 1763 - 1768. [Abstract] [Full Text] [PDF]

				O. Lindner, J. Sorensen, J. Vogt, E. Fricke, D. Baller, D. Horstkotte, and W. Burchert Cardiac Efficiency and Oxygen Consumption Measured with 11C-Acetate PET After Long-Term Cardiac Resynchronization Therapy J. Nucl. Med., March 1, 2006; 47(3): 378 - 383. [Abstract] [Full Text] [PDF]

				J. J. Bax, T. Abraham, S. S. Barold, O. A. Breithardt, J. W.H. Fung, S. Garrigue, J. Gorcsan III, D. L. Hayes, D. A. Kass, J. Knuuti, et al. Cardiac Resynchronization Therapy: Part 2--Issues During and After Device Implantation and Unresolved Questions J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2168 - 2182. [Abstract] [Full Text] [PDF]

				C. Stellbrink Heart rate, regularity, and synchronicity in heart failure: a tale of three brothers Eur. Heart J., April 1, 2005; 26(7): 637 - 638. [Full Text] [PDF]

				O. Lindner, J. Vogt, D. Baller, A. Kammeier, P. Wielepp, J. Holzinger, B. Lamp, D. Horstkotte, and W. Burchert Global and regional myocardial oxygen consumption and blood flow in severe cardiomyopathy with left bundle branch block Eur J Heart Fail, March 2, 2005; 7(2): 225 - 230. [Abstract] [Full Text] [PDF]

				O. Lindner, J. Vogt, A. Kammeier, P. Wielepp, J. Holzinger, D. Baller, B. Lamp, B. Hansky, R. Korfer, D. Horstkotte, et al. Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy Eur. Heart J., January 1, 2005; 26(1): 70 - 76. [Abstract] [Full Text] [PDF]

				K. Vernooy, X. A.A.M. Verbeek, M. Peschar, H. J.G.M. Crijns, T. Arts, R. N.M. Cornelussen, and F. W. Prinzen Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion Eur. Heart J., January 1, 2005; 26(1): 91 - 98. [Abstract] [Full Text] [PDF]

				N. Preumont, J.-L. Jansens, G. Berkenboom, P. van de Borne, E. Stoupel, and S. Goldman Effects of right ventricular pacing on regional myocardial glucose metabolism Europace, January 1, 2005; 7(6): 584 - 591. [Abstract] [Full Text] [PDF]

				R. J. Gibbons and P. A. Araoz The year in cardiac imaging J. Am. Coll. Cardiol., November 16, 2004; 44(10): 1937 - 1944. [Full Text] [PDF]

				P. Knaapen, L. M.C. van Campen, C. C. de Cock, M. J.W. Gotte, C. A. Visser, A. A. Lammertsma, and F. C. Visser Effects of Cardiac Resynchronization Therapy on Myocardial Perfusion Reserve Circulation, August 10, 2004; 110(6): 646 - 651. [Abstract] [Full Text] [PDF]

				M. R. Mehra and B. H. Greenberg Cardiac resynchronization therapy: caveat medicus! J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1145 - 1148. [Abstract] [Full Text] [PDF]

				R. Sciagra, M. Giaccardi, M. C. Porciani, A. Colella, A. Michelucci, P. Pieragnoli, G. Gensini, A. Pupi, and L. Padeletti Myocardial Perfusion Imaging Using Gated SPECT in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy J. Nucl. Med., February 1, 2004; 45(2): 164 - 168. [Abstract] [Full Text] [PDF]